The British government became on Monday the first country to approve the use of a COVID-19 vaccine customized to protect against the Omicron coronavirus strain. The Medicines and Healthcare products Regulatory Agency (MHRA) authorized Moderna’s updated COVID-19 jab for use in adults older than 18 years, paving the way for a booster campaign this fall.
“This bivalent vaccine has an important role to play in protecting people in the UK from COVID-19 as we enter the winter months,” Moderna’s Chief Executive Stephane Bancel commented on the MHRA’s decision. The vaccine protects both against the original coronavirus strain and the Omicron variant, the agency concluded.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
